Drug Information Association
This article was originally published in The Tan Sheet
Executive Summary
Holding May 24-25 workshop in Philadelphia entitled "Nonprescription Drug Development: The Evolving Global Environment." The three meeting sessions are on the clinical evidence required for new OTCs, self-medication in the global marketplace, and "evolution of regulation; learning from each other." FDA Office of OTC Drugs Director-apparent Michael Weintraub, MD, is listed as one of the speakers. To register, call DIA at (215) 628-2288.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning